Trex Company Reports Strong Results in Second Quarter
WINCHESTER, Va.–(BUSINESS WIRE)–Trex Company, Inc. (NYSE:TREX), the world’s #1 brand of composite decking and railing and leader…
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
TORRANCE, Calif.–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical…
Stock Analysis
ZoomInfo Announces Second Quarter 2021 Financial Results
VANCOUVER, Wash.–(BUSINESS WIRE)–ZoomInfo, (NASDAQ: ZI) a global leader in modern go-to-market software, data, and intelligence,…
Continental Resources Delivers Outstanding 2Q21 Results Driving Robust Cash Flow & Exceptional Shareholder Value
• $289.3 Million Net Income; $0.79 per Diluted Share ($332.8 Million Adjusted Net Income; $0.91 per Adjusted Share (Non-GAAP))…
Simon Property Group Reports Second Quarter 2021 Results And Increases Full Year 2021 Guidance And Raises Quarterly Dividend
Simon, a global leader in the ownership of premier shopping, dining, entertainment and mixed-use destinations, today reported…
Deepinder Goyal interview; ED probes payment gateways
During his first media interview after Zomato’s record-breaking IPO, founder and CEO Deepinder Goyal told us the company’s stellar…
Ultra Clean Reports Second Quarter 2021 Financial Results
HAYWARD, Calif., Aug. 2, 2021 /PRNewswire/ — Ultra Clean Holdings, Inc. (Nasdaq: UCTT), today reported its financial results…
Ramaco Resources, Inc. Reports Second Quarter 2021 Financial Results
Net income was $9.9 million (EPS of $0.23) and Adjusted EBITDA was $18.1 million for the second quarter of 2021. Adjusted EBITDA…
Stock Analysis
Ramaco Resources, Inc. Reports Second Quarter 2021 Financial Results
LEXINGTON, Ky., Aug. 2, 2021 /PRNewswire/ — Net income was $9.9 million (EPS of $0.23) and Adjusted EBITDA was $18.1 million…
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
BURLINGAME, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical…